Gradient Investments’s Core Laboratories CLB Stock Holding History

Gradient Investments’s Portfolio CLB Stock Details CLB Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,200	Closed	-$24.3K	–	471
2024 Q2	$24.3K	Hold	1,200	–	–	﹤0.01%	603
2024 Q1	$20.5K	Hold	1,200	–	–	﹤0.01%	537
2023 Q4	$21.2K	Hold	1,200	–	–	﹤0.01%	697
2023 Q3	$28.8K	Hold	1,200	–	–	﹤0.01%	606
2023 Q2	$27.9K	Hold	1,200	–	–	﹤0.01%	623
2023 Q1	$26.5K	Hold	1,200	–	–	﹤0.01%	620
2022 Q4	$24.3K	Hold	1,200	–	–	﹤0.01%	656
2022 Q3	$16K	Hold	1,200	–	–	﹤0.01%	698
2022 Q2	$24K	Hold	1,200	–	–	﹤0.01%	610
2022 Q1	$38K	Hold	1,200	–	–	﹤0.01%	524
2021 Q4	$27K	Hold	1,200	–	–	﹤0.01%	601
2021 Q3	$33K	Hold	1,200	–	–	﹤0.01%	539
2021 Q2	$47K	Hold	1,200	–	–	﹤0.01%	475
2021 Q1	$35K	Hold	1,200	–	–	﹤0.01%	519
2020 Q4	$18K	Hold	1,200	–	–	﹤0.01%	589
2020 Q3	$18K	Hold	1,200	–	–	﹤0.01%	593
2020 Q2	$24K	Hold	1,200	–	–	﹤0.01%	496
2020 Q1	$12K	Hold	1,200	–	–	﹤0.01%	609
2019 Q4	$45K	Hold	1,200	–	–	﹤0.01%	418
2019 Q3	$56K	Hold	1,200	–	–	﹤0.01%	369
2019 Q2	$63K	Hold	1,200	–	–	﹤0.01%	353
2019 Q1	$83K	Hold	1,200	–	–	0.01%	298
2018 Q4	$72K	Sell	1,200 -19	-2%	-$1.14K	﹤0.01%	300
2018 Q3	$141K	Buy	1,219 +19	+2%	+$2.2K	0.01%	256
2018 Q2	$151K	Hold	1,200	–	–	0.01%	247
2018 Q1	$130K	Buy	1,200 +1,186	+8,471%	+$128K	0.01%	257
2017 Q4	$2K	Buy	+14	New	+$2K	﹤0.01%	800
2017 Q3	–	Sell	-1,200	Closed	-$122K	–	304
2017 Q2	$122K	Hold	1,200	–	–	0.01%	242
2017 Q1	$139K	Hold	1,200	–	–	0.01%	238
2016 Q4	$144K	Hold	1,200	–	–	0.01%	195
2016 Q3	$135K	Hold	1,200	–	–	0.01%	196
2016 Q2	$149K	Hold	1,200	–	–	0.02%	196
2016 Q1	$135K	Hold	1,200	–	–	0.02%	196
2015 Q4	$130K	Hold	1,200	–	–	0.02%	193
2015 Q3	$120K	Hold	1,200	–	–	0.02%	186
2015 Q2	$137K	Hold	1,200	–	–	0.02%	186
2015 Q1	$125K	Hold	1,200	–	–	0.02%	187
2014 Q4	$145K	Hold	1,200	–	–	0.02%	170
2014 Q3	$176K	Hold	1,200	–	–	0.03%	159
2014 Q2	$200K	Hold	1,200	–	–	0.04%	157
2014 Q1	$238K	Hold	1,200	–	–	0.06%	150
2013 Q4	$229K	Hold	1,200	–	–	0.06%	153
2013 Q3	$203K	Hold	1,200	–	–	0.06%	110
2013 Q2	$182K	Buy	+1,200	New	+$182K	0.07%	111